Authors
Latest:
Niche pharmacies serve children and the elderlySpecialty pharmacies are developing to meet the growing needs of children and senior citizens.
Latest:
Drug Topics CPE accreditor begins 3-year service to AACPDuring the American Association of Colleges of Pharmacy (AACP) Annual Meeting in Kissimmee, Fla. in mid-July, Jill Fitzgerald, PharmD, who is Drug Topics CPE accreditor, was sworn in as chair-elect to the AACP Continuing Professional Education Section.
Latest:
Pipeline drugs 2010Categories to watch in this year's diverse drug pipeline include oral agents to treat multiple sclerosis and a host of new diabetes, cardiovascular, and pain-management products.
Latest:
Is the pharmacist shortage over?Increasing enrollment in pharmacy schools and changing economic factors appear to have eased the national pharmacist shortage. In order to plan appropriately for all stakeholders, we need to quantify the numbers when we talk about a pharmacist shortage.
Latest:
Opinion: Compounding Pharmacists Must Rebuild the IndustryFour steps that compounding pharmacists must take to restore their credibility.
Latest:
A retail pharmacist examines the consequences of working in a fishbowlDoctors don't do it. Attorneys don't do it. Physical therapists, insurance agents, title agents, audiologist, and nurse practitioners don't do it. Who came up with the fishbowl model of retail pharmacy anyway?
Latest:
Continuous Glucose Monitors Useful for Predicting Pre-DiabetesWhen employed as a prescreening tool, care must be taken to avoid overdiagnosis of healthy individuals without diabetes.
Latest:
Drug Topics' 2010 business outlook surveyRespondents to this year's business outlook survey are generally upbeat about the business their pharmacies are doing and their prospects for the coming year.
Latest:
FDA warns against prolonged use of magnesium sulfate to stop preterm laborFDA advised healthcare professionals not to use magnesium sulfate injection for more than 5-7 days to stop preterm labor in pregnant women.
Latest:
Opinion: PBM Hocus Pocus Harming Seniors, Small Business PharmaciesPolicymakers have the power to get pharmacy benefit managers under control.
Latest:
Launch Your Own Diabetes Prevention ProgramThe CDC estimates that 83 million Americans have prediabetes and that 84% of them don’t know it and community pharmacy can play a major role in preventing diabetes.
Latest:
Drug delivery systems: Multiple- vs. single-doseAll hospital and health systems must decide whether to use multiple-dose vials or single-dose vials of drugs, a decision that usually rests on two considerations: Cost reduction and patient safety. The pros and cons of the two systems lead to an inescapable conclusion.
Latest:
Problem-solving in the pharmacyConfronted with these three common scenarios in your daily practice of pharmacy, what would you do?
Latest:
Collaborative practice agreementsWhen pharmacists manage drug therapy for physicians, diabetes patients see a significant improvement in key measures.
Latest:
Immunizations without prescriptions available at some Good Neighbor pharmaciesGood Neighbor Pharmacy stores in 19 states are now providing immunization services to patients without doctor’s prescriptions.
Latest:
Drug Topics Top 10: Most Read Stories From April 2024Check out this list of our 10 most read stories from April 2024.
Latest:
Oral oncology drugsThe management of oral oncology drugs is an unending series of responsibilities involving safety issues, billing requirements, patient needs, prescriber details, and reimbursement challenges.
Latest:
COVID-19 Vaccination Rates More Sluggish in Children Than AdultsStudy links discrepancy to adults’ misbeliefs about vaccine safety
Latest:
R.Ph. named director of UConn's Evidence-based Practice CenterThe Agency for Healthcare Research and Quality in the Department of Health and Human Services recently awarded the University of Connecticut a 5-year contract and up to $1 million per year to establish a new Evidence-based Practice Center.
Latest:
FDA's stand on compounding is bad for R.Ph.s and patientsA compounding leader takes issue with FDA's position that compounding is the production of a new drug that needs to be approved.
Latest:
Drug prices can't depend on who's buyingIn the prescription drug market, discriminatory pricing is common for independent community pharmacies and their patients. This fall, a Federal District Court in New York will consider a critical case: Drug Mart Pharmacy Corp. et a. v. American Home Products Corp. et al. The outcome of the case may determine whether discriminatory pricing techniques are illegal.
Latest:
Retail pharmacy and the diabetes epidemicMore than 23 million Americans, close to 8 percent of the population, have diabetes. For drugstores, the medical nature of their retail business makes them the outlet of choice for shoppers purchasing diabetes products. Retail pharmacists may choose to maximize patient awareness by placing their diabetes-care display and educational literature near the pharmacy counter.
